Blog
All Articles for Providers
Reinstating PSA Testing
While routine PSA testing has significantly declined since 2008, the incidence of metastatic prostate cancer has increased for men 45 and older across all races, ethnicities, and geographic locations in the US. Those trends plus the development of prostate cancer biomarkers to help prevent unnecessary biopsies and treatment support the return of routine PSA testing.
%s